Ultragenyx Pharmaceutical, Inc. (RARE)
35.98
-0.32
(-0.87%)
USD |
NASDAQ |
Dec 10, 16:00
35.98
0.00 (0.00%)
After-Hours: 19:03
Ultragenyx Pharmaceutical Market Cap: 3.472B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 76.34B |
| Amicus Therapeutics, Inc. | 3.039B |
| Geron Corp. | 826.67M |
| Ionis Pharmaceuticals, Inc. | 12.74B |
| Vertex Pharmaceuticals, Inc. | 112.79B |
Market Cap Related Metrics
| PS Ratio | 5.567 |
| Price to Book Value | 379.05 |
| Price | 35.98 |
| Earnings Yield | -16.50% |